Asthma in elite athletes: Pathogenesis, diagnosis, differential diagnoses, and treatment

Physician and Sportsmedicine

Volumn 39, Issue 3, 2011, Pages 163-171

  Pedersen, Lars ^a,b   Elers, Jimmi ^b   Backer, Vibeke ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Airway hyper responsiveness; Exercise; Exercise induced bronchoconstriction; Exercise induced laryngomalacia; Vocal cord dysfunction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; GLUCOCORTICOID; METHACHOLINE; MONTELUKAST; PLACEBO; SALBUTAMOL; SALMETEROL; ZILEUTON; ANTIASTHMATIC AGENT;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATHLETE; BLOOD GAS ANALYSIS; COUGHING; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE INDUCED ASTHMA; EXPERIMENTAL BRONCHOCONSTRICTION; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; HYPERVENTILATION; LARYNGOMALACIA; LARYNGOSCOPY; LUNG FUNCTION; MORTALITY; MUSCLE CONTRACTION; PREVALENCE; RESPIRATORY TRACT INFLAMMATION; VOCAL CORD DISORDER; BRONCHOSPASM; DIFFERENTIAL DIAGNOSIS; DOPING; EXERCISE TEST; GAS MASK; INHALATION TEST; NUTRITIONAL SUPPORT; POLLEN; REVIEW;

ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; ATHLETES; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; DIAGNOSIS, DIFFERENTIAL; DOPING IN SPORTS; EXERCISE TEST; HUMANS; NUTRITIONAL SUPPORT; POLLEN; RESPIRATORY PROTECTIVE DEVICES;

EID: 84856203875     PISSN: 00913847     EISSN: 23263660     Source Type: Journal    
DOI: 10.3810/psm.2011.09.1932     Document Type: Article

References (98)

1. The Global Strategy for Asthma Management and Prevention. http://www.ginasthma.org. Accessed October 20, 2010.
2. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway infl ammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161(6):2086-2091.
3. Sue-Chu M, Larsson L, Bjermer L. Prevalence of asthma in young crosscountry skiers in central Scandinavia: differences between Norway and Sweden. Respir Med. 1996;90(2):99-105.
4. Larsson K, Ohlsén P, Larsson L, Malmberg P, Rydström PO, Ulriksen H. High prevalence of asthma in cross country skiers. BMJ. 1993;307(6915):1326-1329.
5. Sue-Chu M, Karjalainen EM, Altraja A, et al. Lymphoid aggregates in endobronchial biopsies from young elite cross-country skiers. Am J Respir Crit Care Med. 1998;158(2):597-601.
6. Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and fi eld exercise challenge in elite cross-country skiers. Br J Sports Med. 2010;44(11):827-832.
7. Provost-Craig MA, Arbour KS, Sestili DC, Chabalko JJ, Ekinci E. The incidence of exercise-induced bronchospasm in competitive fi gure skaters. J Asthma. 1996;33(1):67-71.
8. Mannix ET, Farber MO, Palange P, Galassetti P, Manfredi F. Exerciseinduced asthma in fi gure skaters. Chest. 1996;109(2):312-315.
9. Mannix ET, Manfredi F, Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in fi gure skaters. Chest. 1999;115(3):649-653.
10. Leuppi JD, Kuhn M, Comminot C, Reinhart WH. High prevalence of bronchial hyperresponsiveness and asthma in ice hockey players. Eur Respir J. 1998;12(1):13-16.
11. Lumme A, Haahtela T, Ounap J, et al. Airway infl ammation, bronchial hyperresponsiveness and asthma in elite ice hockey players. Eur Respir J. 2003;22(1):113-117.
12. Zwick H, Popp W, Budik G, Wanke T, Rauscher H. Increased sensitization to aeroallergens in competitive swimmers. Lung. 1990;168(2):111-115.
13. Langdeau JB, Turcotte H, Bowie DM, Jobin J, Desgagné P, Boulet LP. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161(5):1479-1484.
14. Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol. 1998;101(5):646-652.
15. Helenius IJ, Rytila P, Metso T, Haahtela T, Venge P, Tikkanen HO. Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers. Allergy. 1998;53(4):346-352.
16. Pedersen L, Winther S, Backer V, Anderson SD, Larsen KR. Airway responses to eucapnic hyperpnea, exercise, and methacholine in elite swimmers. Med Sci Sports Exerc. 2008;40(9):1567-1572.
17. Stadelmann K, Stensrud T, Carlsen KH. Respiratory symptoms and bronchial responsiveness in competitive swimmers. Med Sci Sports Exerc. 2011;43(3):375-381.
18. Cockcroft DW, Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol. 2006;118(3):551-559.
19. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is… J Allergy Clin Immunol. 2000;106(3):453-459.
20. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes?. J Allergy Clin Immunol. 2000;106(3):419-428.
21. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction:pathogenesis. Curr Allergy Asthma Rep. 2005;5(2):116-122.
22. Joos GF, O’Connor B, Anderson SD, et al; ERS Task Force. Indirect airway challenges. Eur Respir J. 2003;21(6):1050-1068.
23. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. J Clin Invest. 1986;78(1):18-25.
24. McFadden ER Jr, Nelson JA, Skowronski ME, Lenner KA. Thermally induced asthma and airway drying. Am J Respir Crit Care Med. 1999;160(1):221-226.
25. Anderson SD. Is there a unifying hypothesis for exercise-induced asthma? J Allergy Clin Immunol. 1984;73(5 pt 2):660-665.
26. Freed AN, Anderson SD, Daviskas E. Thermally induced asthma and airway drying. Am J Respir Crit Care Med. 2000;161(6):2112-2113.
27. Anderson SD, Kippelen P. Airway injury as a mechanism for exerciseinduced bronchoconstriction in elite athletes. J Allergy Clin Immunol. 2008;122(2):225-235.
28. Chimenti L, Morici G, Paternò A, et al. Bronchial epithelial damage after a half-marathon in nonasthmatic amateur runners. Am J Physiol Lung Cell Mol Physiol. 2010;298(6):L857-L862.
29. Bonsignore MR, Morici G, Vignola AM, et al. Increased airway infl ammatory cells in endurance athletes: what do they mean?. Clin Exp Allergy. 2003;33(1):14-21.
30. Chimenti L, Morici G, Paternò A, et al. Endurance training damages small airway epithelium in mice. Am J Respir Crit Care Med. 2007;175(5):442-449.
31. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med. 1998;32(2):125-129.
32. Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax. 1997;52(2):157-160.
33. Salonen RO, Pennanen AS, Vahteristo M, Korkeila P, Alm S, Randell JT. Health risk assessment of indoor air pollution in Finnish ice arenas. Environ Int. 2008;34(1):51-57.
34. Rundell KW. Pulmonary function decay in women ice hockey players:is there a relationship to ice rink air quality?. Inhal Toxicol. 2004;16(3):117-123.
35. Rundell KW. High levels of airborne ultrafi ne and fi ne particulate matter in indoor ice arenas. Inhal Toxicol. 2003;15(3):237-250.
36. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes:challenges for diagnosis. J Allergy Clin Immunol. 2002;110(3):374-380.
37. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39(9):1487-1492.
38. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33(2):208-213.
39. Beta2-adrenoceptor agonists and the Olympic Games in Beijing. http://multimedia.olympic.org/pdf/en_report_1302.pdf. Accessed April 6, 2008.
40. Medical Information to Support the Decisions of TUEC Asthma. http://www.wada-ama.org/Documents/Science_Medicine/Medical_info_ to_support_TUECs/WADA_Medical_info_Asthma_V3_EN.0.pdf. Accessed January 12, 2011.
41. Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J. 2000;16(3):514-533.
42. Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med. 2008;14(1):39-45.
43. Anderson SD, Brannan JD. Methods for “indirect” challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24(1):27-54.
44. Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical signifi cance. Chest. 2010;138(2 suppl):18S-24S.
45. Cockcroft DW, Davis BE. Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep. 2009;9(3):247-253.
46. Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax. 1984;39(7):500-504.
47. Norval J, Perry CP, Anderson SD. Responses to methacholine and eucapnic voluntary hyperpnea in relation to baseline lung function. Respirology. 2007;12(suppl 1):A2.
48. Moreno RH, Hogg JC, Paré PD. Mechanics of airway narrowing. Am Rev Respir Dis. 1986;133(6):1171-1180.
49. Stensrud T, Mykland KV, Gabrielsen K, Carlsen KH. Bronchial hyperresponsiveness in skiers: fi eld test versus methacholine provocation?. Med Sci Sports Exerc. 2007;39(10):1681-1686.
50. Stickland MK, Spooner CH, Dryden DM, Rowe BH. The need for standardization in exercise challenge testing for exercise-induced asthma/bronchoconstriction. J Allergy Clin Immunol. 2010;126(4):878-880.e6.
51. Newacheck PW, Halfon N. Prevalence and impact of disabling chronic conditions in childhood. Am J Public Health. 1998;88(4):610-617.
52. Newacheck PW, Halfon N. Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med. 2000;154(3):287-293.
53. Tilles SA, Inglis AF. Masqueraders of exercise-induced vocal cord dysfunction. J Allergy Clin Immunol. 2009;124(2):377-378, 378.e1-e3.
54. Weiler JM, Bonini S, Coifman R, et al; Ad Hoc Committee of Sports Medicine Committee of American Academy of Allergy, Asthma & Immunology. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119(6):1349-1358.
55. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest. 2003;123(2):468-474.
56. Parsons JP, Benninger C, Hawley MP, Philips G, Forrest LA, Mastronarde JG. Vocal cord dysfunction: beyond severe asthma. Respir Med. 2010;104(4):504-509.
57. Greenberger PA, Grammer LC. Pulmonary disorders, including vocal cord dysfunction. J Allergy Clin Immunol. 2010;125(2 suppl 2):S248-S254.
58. Watson MA, King CS, Holley AB, Greenburg DL, Mikita JA. Clinical and lung-function variables associated with vocal cord dysfunction. Respir Care. 2009;54(4):467-473.
59. Wilson JJ, Wilson EM. Practical management: vocal cord dysfunction in athletes. Clin J Sport Med. 2006;16(4):357-360.
60. Rhodes RK. Diagnosing vocal cord dysfunction in young athletes. J Am Acad Nurse Pract. 2008;20(12):608-613.
61. Heimdal JH, Roksund OD, Halvorsen T, Skadberg BT, Olofsson J. Continuous laryngoscopy exercise test: a method for visualizing laryngeal dysfunction during exercise. Laryngoscope. 2006;116(1):52-57.
62. Christensen P, Thomsen SF, Rasmussen N, Backer V. Exercise-induced laryngeal obstructions objectively assessed using EILOMEA. Eur Arch Otorhinolaryngol. 2010;267(3):401-407.
63. Abu-Hasan M, Tannous B, Weinberger M. Exercise-induced dyspnea in children and adolescents: if not asthma then what?. Ann Allergy Asthma Immunol. 2005;94(3):366-371.
64. Seear M, Wensley D, West N. How accurate is the diagnosis of exercise induced asthma among Vancouver schoolchildren?. Arch Dis Child. 2005;90(9):898-902.
65. Weinberger M. Exercise induced dyspnoea: if not asthma, then what?. Arch Dis Child. 2006;91(6):543-544.
66. Tilles SA. Exercise-induced respiratory symptoms: an epidemic among adolescents. Ann Allergy Asthma Immunol. 2010;104(5):361-367.
67. Hammo AH, Weinberger MM. Exercise-induced hyperventilation:a pseudoasthma syndrome. Ann Allergy Asthma Immunol. 1999;82(6):574-578.
68. Reiff DB, Choudry NB, Pride NB, Ind PW. The effect of prolonged submaximal warm-up exercise on exercise-induced asthma. Am Rev Respir Dis. 1989;139(2):479-484.
69. McKenzie DC, McLuckie SL, Stirling DR. The protective effects of continuous and interval exercise in athletes with exercise-induced asthma. Med Sci Sports Exerc. 1994;26(8):951-956.
70. Mickleborough TD, Lindley MR, Turner LA. Comparative effects of a high-intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int J Sports Med. 2007;28(6):456-462.
71. Millqvist E, Bengtsson U, Löwhagen O. Combining a beta2-agonist with a face mask to prevent exercise-induced bronchoconstriction. Allergy. 2000;55(7):672-675.
72. Beuther DA, Martin RJ. Effi cacy of a heat exchanger mask in cold exercise-induced asthma. Chest. 2006;129(5):1188-1193.
73. Mickleborough TD. Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma. J Asthma. 2005;42(5):305-314.
74. Simpson JL, Scott R, Boyle MJ, Gibson PG. Infl ammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54-61.
75. Carlsen KH, Anderson SD, Bjermer L, et al; European Respiratory Society; European Academy of Allergy and Clinical Immunology. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy. 2008;63(4):387-403.
76. Sue-Chu M, Karjalainen EM, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airway infl ammation in bronchoalveolar lavage fl uid and bronchial biopsies in cross-country skiers. Respiration. 2000;67(4):417-425.
77. Helenius I, Lumme A, Ounap J, et al. No effect of montelukast on asthmalike symptoms in elite ice hockey players. Allergy. 2004;59(1):39-44.
78. Anderson SD, Caillaud C, Brannan JD. Beta2-agonists and exerciseinduced asthma. Clin Rev Allergy Immunol. 2006;31(2-3):163-180.
79. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med. 1993;87(5):331-344.
80. Lazarus SC, Boushey HA, Fahy JV, et al; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Longacting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285(20):2583-2593.
81. Reynolds NA, Lyseng-Williamson KA, Wiseman LR. Inhaled salmeterol/fl uticasone propionate: a review of its use in asthma. Drugs. 2005;65(12):1715-1734.
82. Noonan M, Rosenwasser LJ, Martin P, O’Brien CD, O’Dowd L. Effi cacy and safety of budesonide and formoterol in one pressurised metereddose inhaler in adults and adolescents with moderate to severe asthma:a randomized clinical trial. Drugs. 2006;66(17):2235-2254.
83. Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establisning Therapy (FACET) International Study Group. N Engl J Med. 1997;337(20):1405-1411.
84. Hancox RJ, Taylor DR. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. BioDrugs. 2001;15(1):11-24.
85. Hancox RJ, Subbarao P, Kamada D, et al. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002;165(8):1068-1070.
86. Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005;99(5):566-571.
87. Elers J, Strandbygaard U, Pedersen L, Backer V. Daily use of salmeterol causes tolerance to bronchodilation with terbutaline in asthmatic subjects. Open Respir Med J. 2010:4:48-50.
88. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway infl ammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis. 1992;145(4 pt 1):890-899.
89. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332-336.
90. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax. 1991;46(11):811-816.
91. Löfdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319(7202):87-90.
92. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotrienereceptor antagonist, for the treatment of mild asthma and exerciseinduced bronchoconstriction. N Engl J Med. 1998;339(3):147-152.
93. de Benedictis FM, del Giudice MM, Forenza N, Decimo F, de Benedictis D, Capristo A. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J. 2006;28(2):291-295.
94. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med. 2000;132(2):97-104.
95. de Benedictis FM, Vaccher S, de Benedictis D. Montelukast sodium for exercise-induced asthma. Drugs Today (Barc). 2008;44(11):845-855.
96. Kippelen P, Larsson J, Anderson SD, Brannan JD, Dahlén B, Dahlén SE. Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc. 2010;42(10):1853-1860.
97. World Anti-Doping Agency. http://www.wada-ama.org. Accessed July 18, 2011.
98. US Anti-Doping Agency. http://www.usada.org. Accessed July 17, 2011.